Stockopedia rates Swedencare AB (publ) as a Speculative High Flyer . 1 brokers The Company operates as a provider of various products for animal health,

Swedencare USA announced that Swedencare AB, global parent company of Swedencare USA, has acquired the operations of Animal Pharmaceuticals Inc. Through the acquisition Swedencare will receive a comprehensive product portfolio of supplements and topical products in the premium sector for dogs and cats.

The company’s product groups are represented on approximately fifty markets around the world and are sold through subsidiaries in the Nordics, United States, France, Spain, Greece, Great Britain and Ireland and through an external distribution network. Swedencare AB (publ) avser genomföra en riktad nyemission av aktier som en del i finansieringen av förvärven av Nutravet (UK) Limited och verksamheten i Animal Pharmaceuticals Inc. 24 sep 2020 Swedencare AB (publ) förvärvar verksamhet av amerikanskt djurhälsobolag med fokus på veterinärkanalen Förvärvet av verksamheten i Animal Pharmaceuticals är strukturerat som en rörelseöverlåtelse och sker genom ett nyetablerat amerikanskt dotterbolag till Swedencare, Animal Pharm Care USA, Inc. Köpeskillingen uppgår totalt till cirka 131 MSEK med en eventuell tilläggsköpeskilling om maximalt cirka 87 MSEK och erläggs, beroende på utfallet avseende tilläggsköpeskillingen, genom en kontantlikvid om cirka 91 – 178 MSEK och en riktad nyemission om totalt 251 994 aktier i Swedencare har i enlighet med avtalet avseende förvärvet av verksamheten i Animal Pharmaceuticals, vilket offentliggjordes den 24 september 2020, erlagt en tilläggsköpeskilling om cirka 87 milj Swedencare AB (publ) intends to carry out a directed new share issue as part of the financing of the acquisitions of Nutravet (UK) Limited and the operations conducted by Animal Pharmaceuticals Inc. Thu, Sep 24, 2020 17:33 CET Swedencare. Swedencare är Den organiska tillväxten fortsatte att vara stark även i Q4 2020 men innefattar även förvärven av Animal Pharmaceuticals och Nutravet. Swedencare has in accordance with the agreement regarding the acquisition of the operations of Animal Pharmaceuticals, which was announced on September 24th 2020, paid an additional purchase price Med Animal Pharmaceuticals får vi ytterligare ett veterinärsfokuserat bolag där vi kommer att ha många synergier med Stratford avseende organisation, fullfillment, ekonomi och försäljning. Jason Brown, som även han numera är en stor aktieägare i Swedencare, har grundat företaget och lett det framgångsrikt i 17 år. The Swedencare group, as it looks after the acquisition of Animal Pharmaceuticals and British Nutravet (UK) Limited, which have been made public earlier, had for the 12-months period July 2019 - June 2020 (pro forma) revenue of approximately 332 million SEK with an EBITDA of 104 million SEK, equaling to an EBITDA-margin of 31,3%.

The acquisition of Animal Pharmaceuticals is structured as a business transfer and is made by a newly established US subsidiary to Swedencare, Animal Pharm Care USA, Inc. Swedencare's US subsidiary, Animal Pharm Care USA Inc., has today gained access to the business which was acquired by Animal Pharmaceuticals Inc. on September 24th 2020.The company, founded by Jason Braun in 2003, sells a wide range of products to approximately 8 500 veterinary clinics, making it one of the leaders in the veterinary market in the US. Swedencare AB (publ) intends to carry out a directed new share issue as part of the financing of the acquisitions of Nutravet (UK) Limited and the operations conducted by Animal Pharmaceuticals Inc. Thu, Sep 24, 2020 17:33 CET Swedencare’s US subsidiary, Animal Pharm Care USA Inc., has today gained access to the business which was acquired by Animal Pharmaceuticals Inc. on September 24th 2020. The new Animal Pharmaceuticals will be led by Jason Braun, founder and former owner. Jason Braun will also become one of the major shareholders of Swedencare with a shareholding of 251 994 shares. " Animal Pharmaceuticals has grown and evolved through the industry for over 17 years. Swedencare develop, produce, market, and sell premium products on the global and fast-growing market within animal healthcare for cats, dogs and horses. The product groups ProDen PlaqueOff®, Stratford and NutriScience are represented on approximately fifty markets in all parts of the world through ten subsidiaries in the Nordics, United States, France, Spain, Greece, Great Britain and Ireland Swedencare, a listed company on NASDAQ First North Growth Market, is specialized in pet healthcare and produces partly in own factories, markets and sells premium products on the global and fast-growing market. Swedencare AB (publ) ("Swedencare") acquires the operations of the American Pet Health company, Animal Pharmaceuticals Inc. ("Animal Pharmaceuticals").

Swedencare has in accordance with the agreement regarding the acquisition of the operations of Animal Pharmaceuticals, which was announced on September 24th 2020, paid an additional purchase price of approximately 87 million SEK. Djurhälsobolaget Swedencare har i enlighet med avtalet erlagt en tilläggsköpeskilling om cirka 87 miljoner kronor för förvärvet av Animal Pharmaceuticals.

Jan 5, 2021 Swedencare AB (publ) has from Jan 1st acquired the shares and products on the global and fast-growing market within animal healthcare for cats, well as ProDen PlaqueOff® as the largest for oral health to dogs and c

The company, founded by Jason Braun in 2003, sells a wide range of products to approximately 8 500 veterinary clinics, making it one of the leaders in the veterinary market in the US. The product range, which is developed in house, covers a number of therapy areas of which dermatology and grooming stands for almost 60%. Swedencare AB (publ) / Swedencare AB (publ) intends to carry out a directed new share issue as part of the financing of the acquisitions of Nutravet (UK) Limited and the operations conducted by Animal Pharmaceuticals Inc. Swedencare has in accordance with the agreement regarding the acquisition of the operations of Animal Pharmaceuticals, which was announced on September 24th 2020, paid an additional purchase price of approximately 87 million SEK. Animal Pharmaceuticals is a pharmaceuticals company based out of 1140 Holland Dr, Boca Raton, Florida, United States.

Swedencare announced it has paid an additional purchase price of approximately SEK87 million ($10.3 million) for the acquisition of US firm Animal Pharmaceuticals. The additional payment is based on Animal Pharmaceuticals’ EBITDA of $2.7 million during July 2019 to June 2020.

Swedencare AB (publ) fastställer tillläggsköpeskillingen för förvärvet av Animal Pharmaceuticals till maxbeloppet om cirka 87 miljoner SEK (”Animal Pharmaceuticals”).

OBX Index ®. OMX S30 ® Swedbank A. SwedenCare. Swedish Match. "Att vi skulle leverera en rekordrapport avseende omsättning och resultat var väntat med tanke på våra förvärv av Animal Pharmaceuticals och Swedencare’s mission is to provide the global pet market a broad portfolio of premium products in animal health, distributed to veterinarians, pet stores and pharmacies through an effective distribution network, supplemented with local retailers. Swedencare AB (publ) (”Swedencare”) acquires the US ecommerce company Holden2 LLC (“Holden2&rdquo Swedencare AB (publ) sets the additional purchase price for the acquisition of Animal Pharmaceuticals at the maximum amount of approximately 87 million SEK (10MUSD) 2020-11-17 17:00 Swedencare USA is the manufacturer in the US and Canada for ProDen PlaqueOff ®, an oral health care product from Sweden. PlaqueOff ® has become the proven and trusted dental product for pets among those who have used it.
Systembolag brommaplan

$19.99 SwedenCare UK ProDen PlaqueOff Powder Dog and Cat Supply.

040-859 33.
Naturkunskap 1b gamla prov

viaplay jobba hos oss
siba senegal
regering och riksdag
vädret i pajala
varför görs lumbalpunktion
skrota bil själv
härryda kommun kontakt

Swedencare has in accordance with the agreement regarding the acquisition of the operations of Animal Pharmaceuticals, which was

Swedencare AB (publ) sets the additional purchase price for the acquisition of Animal Pharmaceuticals at the maximum amount of approximately 87 million SEK (10MUSD) Publicerad: 2020-11-17 (MFN) Swedencare AB (publ) fastställer tillläggsköpeskillingen för förvärvet av Animal Pharmaceuticals till maxbeloppet om cirka 87 miljoner SEK (10MUSD) Swedencare AB (publ) har slutfört det amerikanska förvärv vilket offentliggjordes den 24 september 2020 tor, okt 01, 2020 16:00 CET. Swedencares amerikanska dotterbolag, Animal Pharm Care USA Inc., har idag tillträtt den verksamhet som förvärvades av Animal Pharmaceuticals Inc. den 24 september 2020. Med Animal Pharmaceuticals får vi ytterligare ett veterinärsfokuserat bolag där vi kommer att ha många synergier med Stratford avseende organisation, fullfillment, ekonomi och försäljning. Jason Brown, som även han numera är en stor aktieägare i Swedencare, har grundat företaget och lett det framgångsrikt i 17 år. • Swedencare AB (publ) determines the additional purchase price for the acquisition of Animal Pharmaceuticals to the maximum amount of approximately 87 MSEK (10 MUSD). • Swedencare AB (publ) signs an agreement to acquire Holden2, an American e-commerce company focusing on pet health products. The Swedencare group, as it looks after the acquisition of Animal Pharmaceuticals and British Nutravet (UK) Limited, which have been made public earlier, had for the 12-months period July 2019 - June 2020 (pro forma) revenue of approximately 332 million SEK with an EBITDA of 104 million SEK, equaling to an EBITDA-margin of 31,3%.